-
American Heart Association joins NSAID education group
EUGENE, Ore. — The American Heart Association has joined a group of patient and provider organizations promoting safe use of a commonly used class of painkillers.
The AHA announced that it had joined the Alliance for the Rational Use of NSAIDs, which refers to nonsteroidal anti-inflammatory drugs, a class that includes the common drug ibuprofen. Other members include the American Academy of Nurse Practitioners and the American Association of Colleges of Pharmacy.
-
Mylan launches generic hypertension drug
PITTSBURGH — The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.
Mylan announced the approval and launch of candesartan cilexetil and hydrochlorothiazide tablets in the 16/12.5-mg, 32/12.5-mg and 32/25-mg strengths. Mylan said it was the first company to submit a complete regulatory approval application for the drug and is thus entitled to 180 days of market exclusivity in which to compete directly with the branded version.